Gene · 23091
Papers1,599
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 1,599
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Roles and therapeutic implications of m6A modification in cancer immunotherapy. | Front Immunol | 2023 | 36960074 | PubTator, text mining | PubMed |
| Effect of N6-methyladenosine methylation-related gene signature for predicting the prognosis of hepatocellular carcinoma patients. | Front Surg | 2023 | 36936652 | PubTator, text mining | PubMed |
| N6-methyladenosine related gene expression signatures for predicting the overall survival and immune responses of patients with colorectal cancer. | Front Genet | 2023 | 36936424 | PubTator, text mining | PubMed |
| Random Forest model reveals the interaction between N6-methyladenosine modifications and RNA-binding proteins. | iScience | 2023 | 36922995 | PubTator, text mining | PubMed |
| Epigenetic and epitranscriptomic regulation of axon regeneration. | Mol Psychiatry | 2023 | 36922674 | PubTator, text mining | PubMed |
| Comprehensive analysis of COMMD10 as a novel prognostic biomarker for gastric cancer. | PeerJ | 2023 | 36919165 | PubTator, text mining | PubMed |
| FTO-mediated m6A modification promotes malignant transformation of gastric mucosal epithelial cells in chronic Cag A+ Helicobacter pylori infection. | J Cancer Res Clin Oncol | 2023 | 36918410 | PubTator, text mining | PubMed |
| N6-methyladenosine (m6A) as a regulator of carcinogenesis and drug resistance by targeting epithelial-mesenchymal transition and cancer stem cells. | Heliyon | 2023 | 36915498 | PubTator, text mining | PubMed |
| A cuproptosis-related signature for predicting the prognosis of gastric cancer. | J Gastrointest Oncol | 2023 | 36915443 | PubTator, text mining | PubMed |
| The Role of m6A Modifications in B-Cell Development and B-Cell-Related Diseases. | Int J Mol Sci | 2023 | 36902149 | PubTator, text mining | PubMed |
| Bioinformatics analysis and verification of m6A related genes based on the construction of keloid diagnostic model. | Int Wound J | 2023 | 36896881 | PubTator, text mining | PubMed |
| RNA N6-methyladenosine modification in female reproductive biology and pathophysiology. | Cell Commun Signal | 2023 | 36894952 | PubTator, text mining | PubMed |
| Comprehensive analysis of cuproptosis-related prognostic gene signature and tumor immune microenvironment in HCC. | Front Genet | 2023 | 36891150 | PubTator, text mining | PubMed |
| The epigenetic regulatory mechanism of PIWI/piRNAs in human cancers. | Mol Cancer | 2023 | 36882835 | PubTator, text mining | PubMed |
| Recent advances in the plant epitranscriptome. | Genome Biol | 2023 | 36882788 | PubTator, text mining | PubMed |
| Emerging role of interaction between m6A and main ncRNAs in gastrointestinal (GI) cancers. | Front Immunol | 2023 | 36875073 | PubTator, text mining | PubMed |
| Epigenetic reprogramming in pancreatic premalignancy and clinical implications. | Front Oncol | 2023 | 36874143 | PubTator, text mining | PubMed |
| A novel RNA modification prognostic signature for predicting the characteristics of the tumor microenvironment in gastric cancer. | Front Oncol | 2023 | 36874129 | PubTator, text mining | PubMed |
| Discovery of lipid-mediated protein-protein interactions in living cells using metabolic labeling with photoactivatable clickable probes. | Chem Sci | 2023 | 36873846 | PubTator, text mining | PubMed |
| Identification of m6A/m5C/m1A-associated LncRNAs for prognostic assessment and immunotherapy in pancreatic cancer. | Sci Rep | 2023 | 36871072 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23091/papers?page=18